Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

 134.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 139.50
  • 52 Week Low: 96.00
  • Currency: UK Pounds
  • Shares Issued: 104.77m
  • Volume: 4,023
  • Market Cap: £140.39m
  • RiskGrade: 72
  • Beta: 0.00

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
22.36% above the market average22.36% above the market average22.36% above the market average22.36% above the market average22.36% above the market average
29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average29.41% above the sector average
1yr Revenue Growth
55.06% below the market average55.06% below the market average55.06% below the market average55.06% below the market average55.06% below the market average
39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
18.67% below the market average18.67% below the market average18.67% below the market average18.67% below the market average18.67% below the market average
23.08% above the sector average23.08% above the sector average23.08% above the sector average23.08% above the sector average23.08% above the sector average
1yr DPS Growth
1.77% above the market average1.77% above the market average1.77% above the market average1.77% above the market average1.77% above the market average
27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
55.63% below the market average55.63% below the market average55.63% below the market average55.63% below the market average55.63% below the market average
84% below the sector average84% below the sector average84% below the sector average84% below the sector average84% below the sector average
Price Book Ratio
23.5% below the market average23.5% below the market average23.5% below the market average23.5% below the market average23.5% below the market average
37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
27.99% above the market average27.99% above the market average27.99% above the market average27.99% above the market average27.99% above the market average
2.56% above the sector average2.56% above the sector average2.56% above the sector average2.56% above the sector average2.56% above the sector average
Price Chg 3m
60.24% above the market average60.24% above the market average60.24% above the market average60.24% above the market average60.24% above the market average
28.21% above the sector average28.21% above the sector average28.21% above the sector average28.21% above the sector average28.21% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
39.20% above the market average39.20% above the market average39.20% above the market average39.20% above the market average39.20% above the market average
15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average
Momentum 20
41.73% above the market average41.73% above the market average41.73% above the market average41.73% above the market average41.73% above the market average
21.05% above the sector average21.05% above the sector average21.05% above the sector average21.05% above the sector average21.05% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
18.66% below the market average18.66% below the market average18.66% below the market average18.66% below the market average18.66% below the market average
18.75% above the sector average18.75% above the sector average18.75% above the sector average18.75% above the sector average18.75% above the sector average
ROCE
74.93% above the market average74.93% above the market average74.93% above the market average74.93% above the market average74.93% above the market average
64.71% above the sector average64.71% above the sector average64.71% above the sector average64.71% above the sector average64.71% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
20.18% above the market average20.18% above the market average20.18% above the market average20.18% above the market average20.18% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average
Forecast EPS
41.49% below the market average41.49% below the market average41.49% below the market average41.49% below the market average41.49% below the market average
11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
43.00% above the market average43.00% above the market average43.00% above the market average43.00% above the market average43.00% above the market average
51.52% above the sector average51.52% above the sector average51.52% above the sector average51.52% above the sector average51.52% above the sector average
Operating Profit Loss
23.46% above the market average23.46% above the market average23.46% above the market average23.46% above the market average23.46% above the market average
31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
29.92% above the market average29.92% above the market average29.92% above the market average29.92% above the market average29.92% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average
Cash
5.79% above the market average5.79% above the market average5.79% above the market average5.79% above the market average5.79% above the market average
25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
14.71% below the market average14.71% below the market average14.71% below the market average14.71% below the market average14.71% below the market average
7.14% below the sector average7.14% below the sector average7.14% below the sector average7.14% below the sector average7.14% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
28.78% above the market average28.78% above the market average28.78% above the market average28.78% above the market average28.78% above the market average
90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 134.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 139.50
52 Week Low 96.00
Volume 4,023
Shares Issued 104.77m
Market Cap £140.39m
Beta 0.00
RiskGrade 72

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
59.08% below the market average59.08% below the market average59.08% below the market average59.08% below the market average59.08% below the market average
77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average
Price Trend
56.31% above the market average56.31% above the market average56.31% above the market average56.31% above the market average56.31% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Income
8.07% below the market average8.07% below the market average8.07% below the market average8.07% below the market average8.07% below the market average
28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average
Growth
30.96% below the market average30.96% below the market average30.96% below the market average30.96% below the market average30.96% below the market average
21.21% below the sector average21.21% below the sector average21.21% below the sector average21.21% below the sector average21.21% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Final Interim
Ex-Div 25-Apr-19 04-Oct-18
Paid 24-May-19 02-Nov-18
Amount 2.75p 1.10p

Trades for 14-Jun-2019

Time Volume / Share Price
14:34 9 @ 133.50p
14:12 1,364 @ 133.00p
13:25 1,100 @ 133.04p
09:43 992 @ 133.04p
09:14 167 @ 133.50p

Cello Health Key Personnel

CEO Mark Scott

Top of Page